Investigation of the Gut Microbiome and Statin Response
Status:
Recruiting
Trial end date:
2023-04-03
Target enrollment:
Participant gender:
Summary
There is evidence that the bacteria that naturally reside in the gut can influence how well
we respond to medications. Therefore this study will look at how rosuvastatin, a medication
used to lower cholesterol levels, may change the bacteria in the gut. Investigators will also
examine how the gut bacteria will affect the ability of rosuvastatin to lower cholesterol
levels. There will be 4 study visits over the course of about 16 weeks.The expected duration
of the study is 2 years. Investigators plan to enroll 100 healthy volunteers during that
time.